About Ordaos
Ordaos is a company based in New York (United States) founded in 2019 by Ulo Palm and Ziwei Liang.. Ordaos has raised $21.49 million across 6 funding rounds from investors including NuFund, VTC Ventures and Route 66 Ventures. Ordaos offers products and services including miniPRO™ and Ordaōs Design Engine. Ordaos operates in a competitive market with competitors including AbSci, LabGenius, immunitoAI, Enpicom and Alkira Bio, among others.
- Headquarter New York, United States
- Founders Ulo Palm, Ziwei Liang
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ordaos, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$21.49 M (USD)
in 6 rounds
-
Latest Funding Round
$337.71 K (USD), Seed
Feb 13, 2025
-
Investors
NuFund
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ordaos
Ordaos offers a comprehensive portfolio of products and services, including miniPRO™ and Ordaōs Design Engine. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
De novo designed mini-proteins for targeted drug discovery applications.
Generative AI tool for creating and optimizing protein sequences.
Unlock access to complete
Funding Insights of Ordaos
Ordaos has successfully raised a total of $21.49M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $337.71 thousand completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Seed — $337,705
-
First Round
First Round
(15 Jun 2022)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2025 | Amount | Seed - Ordaos | Valuation |
investors |
|
| Aug, 2024 | Amount | Seed - Ordaos | Valuation |
investors |
|
| Mar, 2024 | Amount | Seed - Ordaos | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ordaos
Ordaos has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include NuFund, VTC Ventures and Route 66 Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Technology sectors are invested in by NuFund venture capital firm.
|
Founded Year | Domain | Location | |
|
Early stage investments are made by VTC Ventures.
|
Founded Year | Domain | Location | |
|
Early, growth & late stage VC firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ordaos
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ordaos
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ordaos Comparisons
Competitors of Ordaos
Ordaos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AbSci, LabGenius, immunitoAI, Enpicom and Alkira Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based technology is used for recombinant protein production in therapeutics.
|
|
| domain | founded_year | HQ Location |
AI-driven platform for discovering and optimizing therapeutic antibodies for treatments.
|
|
| domain | founded_year | HQ Location |
An AI-based platform for antibody discovery and therapeutics is developed.
|
|
| domain | founded_year | HQ Location |
Developer of bioinformatics platform integrating data, automation, and AI for biologics
|
|
| domain | founded_year | HQ Location |
Therapeutic antibodies targeting complex membrane proteins are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ordaos
Frequently Asked Questions about Ordaos
When was Ordaos founded?
Ordaos was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Where is Ordaos located?
Ordaos is headquartered in New York, United States. It is registered at New York, New York, United States.
Who is the current CEO of Ordaos?
David Longo is the current CEO of Ordaos.
Is Ordaos a funded company?
Ordaos is a funded company, having raised a total of $21.49M across 6 funding rounds to date. The company's 1st funding round was a Seed of $5M, raised on Jun 15, 2022.
What does Ordaos do?
Ordaos was founded in 2019 and is headquartered in New York, United States. An AI accelerator is offered by the company within the biomedical sector, focusing on drug discovery. The platform delivers an AI-driven pipeline that supports researchers in developing novel immunotherapies targeted at oncology and chronic inflammatory diseases. Operations emphasize efficient research workflows for therapeutic advancements.
Who are the top competitors of Ordaos?
Ordaos's top competitors include AbSci, immunitoAI and Enpicom.
What products or services does Ordaos offer?
Ordaos offers miniPRO™ and Ordaōs Design Engine.
Who are Ordaos's investors?
Ordaos has 6 investors. Key investors include NuFund, VTC Ventures, Route 66 Ventures, Banyan Pacific Capital, and Citta Capital.